KromaTiD
PrivateLast Round
Series C
Aug 20, 2025
Total Funding Raised
$14.21M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
KromaTiD is a biotechnology company that provides proprietary single-cell genomic structural analysis products and services to support cell and gene therapy development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KromaTiD Comparables
Compare KromaTiD with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bionano Genomics Inc | 79% | |
| Creative Biolabs | 76% | |
| MaxCyte Inc | 71% | |
KromaTiD Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 20, 2025 | ||||
| Corporate Funding | Apr 21, 2021 | ||||
| Series A | Aug 13, 2019 | ||||
| Grant | Jun 10, 2019 |
KromaTiD Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| First Capital Ventures | Series A |
| BroadOak Capital Partners | Series C, Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 108% MoM, reaching 2.8K.
- Aug 20, 2025
$8M round led by BroadOak Capital Partners.
KromaTiD Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about KromaTiD's valuation, stock price, and market status.